Therapeutic compositions containing a lithium compound and silica
US5814347A · kind A · utility
0Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 6, 1995 |
| Grant date | Sep 29, 1998 |
| Priority date | — |
| Expiry date | Nov 6, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic composition for the treatment of virus-induced cutaneous infections comprises a first material for blocking viral DNA replication and a second finely divided material which absorbs exudated fluid from vesicles. Preferred compositions comprise a lithium compound (as the material for blocking viral DNA replication) and silica (as the material for absorbing exudated fluid from vesicles). An example of composition in accordance with the invention comprises a lithium compound dissolved or suspended in an aqueous silica salt.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.